Bruck Kifle

Array ( [id] => 7756898 [patent_doc_number] => 20120028971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'OXO-HETEROCYCLICALLY SUBSTITUTED ALKYL CARBOXYLIC ACIDS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/201924 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32939 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028971.pdf [firstpage_image] =>[orig_patent_app_number] => 13201924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7801249 [patent_doc_number] => 08129521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'One pot synthesis of tetrazole derivatives of rapamycin' [patent_app_type] => utility [patent_app_number] => 12/711072 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8637 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/129/08129521.pdf [firstpage_image] =>[orig_patent_app_number] => 12711072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8006467 [patent_doc_number] => 08084634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Production method' [patent_app_type] => utility [patent_app_number] => 12/710605 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5084 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084634.pdf [firstpage_image] =>[orig_patent_app_number] => 12710605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8921021 [patent_doc_number] => 08486956 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Forms of rifaximin and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/708836 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 18 [patent_no_of_words] => 18204 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445451 [patent_doc_number] => 20100144716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 12/707890 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36337 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144716.pdf [firstpage_image] =>[orig_patent_app_number] => 12707890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4604767 [patent_doc_number] => 07985747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-26 [patent_title] => 'Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 12/706853 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71278 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/985/07985747.pdf [firstpage_image] =>[orig_patent_app_number] => 12706853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670341 [patent_doc_number] => 20110319610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'DIAZEPINEDIONE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/148728 [patent_app_country] => US [patent_app_date] => 2010-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9940 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733530 [patent_doc_number] => 20120015938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => '1,4-BENZODIAZEPIN-2-ON DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/144090 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9167 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015938.pdf [firstpage_image] =>[orig_patent_app_number] => 13144090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518358 [patent_doc_number] => 20100203007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'NOVEL BENZODIAZEPINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/700131 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 62075 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203007.pdf [firstpage_image] =>[orig_patent_app_number] => 12700131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7581116 [patent_doc_number] => 20110294999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'PROCESS FOR THE SYNTHESIS OF IVABRADINE AND ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID' [patent_app_type] => utility [patent_app_number] => 13/138333 [patent_app_country] => US [patent_app_date] => 2010-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3269 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294999.pdf [firstpage_image] =>[orig_patent_app_number] => 13138333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326854 [patent_doc_number] => 20100197591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => '4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/697715 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48696 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197591.pdf [firstpage_image] =>[orig_patent_app_number] => 12697715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6534953 [patent_doc_number] => 20100204119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => '4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/697658 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35840 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204119.pdf [firstpage_image] =>[orig_patent_app_number] => 12697658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276075 [patent_doc_number] => 20100256171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'SELECTIVE SERINE/THREONINE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/698027 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17261 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256171.pdf [firstpage_image] =>[orig_patent_app_number] => 12698027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173791 [patent_doc_number] => 20120108597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Azaquinazolinediones Chymase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/146765 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9872 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108597.pdf [firstpage_image] =>[orig_patent_app_number] => 13146765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280366 [patent_doc_number] => 20100119510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/691895 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80507 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119510.pdf [firstpage_image] =>[orig_patent_app_number] => 12691895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725562 [patent_doc_number] => 08404678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use' [patent_app_type] => utility [patent_app_number] => 12/689797 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 28086 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12689797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320696 [patent_doc_number] => 20100113419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'CGRP RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/684478 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22468 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113419.pdf [firstpage_image] =>[orig_patent_app_number] => 12684478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6646243 [patent_doc_number] => 20100228023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'ONE STEP PROCESS FOR THE PREPARATION OF SUBSTITUTED 5, 10-DIHYDRODIBENZO [b,e][1, 4]DIAZEPINE-11-ONES' [patent_app_type] => utility [patent_app_number] => 12/684710 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2734 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20100228023.pdf [firstpage_image] =>[orig_patent_app_number] => 12684710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778431 [patent_doc_number] => 20120040961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/143505 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22269 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040961.pdf [firstpage_image] =>[orig_patent_app_number] => 13143505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807267 [patent_doc_number] => 08444917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Ammoximation process' [patent_app_type] => utility [patent_app_number] => 13/139930 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6054 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13139930 [rel_patent_id] =>[rel_patent_doc_number] =>)